Alan Minsk, leader of Arnall Golden Gregory’s Food and Drug practice, will travel to Israel in November, his third trip there this year. He has been visiting Israel for a number of years to attend ILSI-Biomed, the annual Israel life sciences conference in Tel Aviv, to develop business contacts and to share his knowledge of the FDA with early-stage life sciences companies. The frequency of the trips has grown because he had been told by many of the consultants and law firms in Israel that trying to get business there requires more than a once-a-year visit. “Frankly, we have enough business to justify the trips, and I enjoy seeing clients face-to-face.” The success of those trips has led to presentations and a growing roster of clients in the pharmaceutical, medical device, food and cosmetic industries. “We represent more than two dozen life sciences companies in Israel and have contacts at more than 30,” Mr. Minsk says. “Israel is a small country but there is a tremendous amount of exciting technology and innovation.”
Minsk points out that his trips also reflect a personal connection to Israel. “I happen to have gone to a Jewish day school, speak a little Hebrew, and have friends and family there. If I’m going to devote my energies to a foreign country, Israel is the logical choice,” he says, adding that he also advises a number of companies from other countries. Each trip is a whirlwind of dozens of business meetings over a few days interrupted only by a speaking engagement. “I will meet with existing clients and prospective clients. At times, I’ll meet with law firms, consultants and those in the financial community,” he says.
As a member of the AICC’s Medical Committee, Minsk tries to make introductions for Israeli businesses interested in moving to the Southeast. Likewise, the Chamber introduces him to Israeli companies that eventually may need US legal services. “I try to help them with my network, and they’re able to help me network as well,” he concluded.